Resonance Laboratories is an API manufacturer based in India. It holds 8 active US drug master files and one valid CEP across a filed portfolio of 4 molecules. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 7 February 2025 as VAI. Customs aggregates show $570K of exports covering 34 molecules to 18 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Bengaluru, India | 3004483648 |
| Molecule | Regulators | Docs |
|---|---|---|
| Atropine | EDQM, US FDA | 3 |
| Clidinium | US FDA | 2 |
| Glycopyrronium | US FDA | 2 |
| Oxybutynin | US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $240K | 7 |
| 2025 | Not reported | $570K | 18 |
| 2024 | Not reported | $1.1M | 19 |
| 2023 | Not reported | $1.2M | 15 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Resonance Laboratories comes back tiered against every other supplier able to file there.
Start for free